-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - Reference bias in reports of
drug trials. … Exp LIVER
DISEASES/ci
Drug terms AND Exp LIVER
DISEASE/si
subheadings linked to drug name Exp … DRUG NAMEadverse events,
po, to
Exp DRUG NAMEadverse events, to
floating subheadings Drug terms … Drug terms AND (ae OR to OR
co).fs. … terms AND exp DRUG
TOXICITY/
Drug terms AND (exp ADVERSE
DRUG REACTION/ OR Exp Side-
Effect/ )
-
effectivehealthcare.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps
January 01, 2005 - Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs
Timeline
January 01, 2005
Topic Initiated
January 01, 2005
Research Report
Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: C…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
December 06, 2010 - Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) for the treatment RA at the time of the first review. … The Key Questions (KQs)
Question 1: For patients with RA, do drug therapies differ in their ability … Question 3: For patients with RA, do drug therapies differ in harms, tolerability, patient
adherence … Food and Drug
Administration (FDA).
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
November 01, 2016 - dysplasia in preterm infants, interventions intended to target
both the pregnant woman and fetus (a drug … AbbVie expects to complete pivotal trials by November 2016 and then submit a new drug
application. … Food
and Drug Administration approves elagolix, third-party payers may decline to cover the drug … Experts also noted that patients may
prefer this oral drug over injectable alternatives. … elagolix.16,21
4
Acceptance and adoption: Clinicians may be more likely to prescribe an oral drug
-
effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
May 07, 2010 - Food and Drug Administration (FDA) approval status and examples of significant warnings. … X versus an ARB + drug X (e.g., losartan + hydrochlorothiazide [HCTZ] versus enalapril + HCTZ). … We will exclude comparisons of an ACEI + drug X versus an ARB + drug Y (e.g., enalapril + manidipine … “ACE inhibitors” or unspecified “ARBs” vs. unspecified “ACEIs”
- Include ACEI + drug X vs. … ARB + drug X (e.g., losartan + HCTZ vs. enalapril + HCTZ)
- Exclude ACEI + drug X vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Food and Drug
Administration (FDA)-approved medication for reversing opioid overdose. … Food and Drug Administration (FDA) priority review for Evzio was based
on evaluation of a series of … -based
online aggregator of prescription-drug prices, lists retail prices for Evzio ranging from $588 … Food
and Drug Administration (FDA), Center for Drug
Evaluation and Research (CDER); 2014 Apr 3. … Food and Drug Administration
(FDA); 2014 Apr 03 [accessed 2014 May 27].
[3 p].
-
effectivehealthcare.ahrq.gov/products/headaches-pregnancy/protocol
November 12, 2019 - Other drug within class. … Same drug(s), different route, treatment duration, initiation time, or other aspect. … Other drug within class. … Same drug(s), different route, treatment duration, initiation time, or other aspect. … Curr Drug Metab. 2012 May 1;13(4):474-90. PMID: 22299823.
15. U.S. Food and Drug Administration.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
March 01, 2012 - All that can be said is
that a particular drug or class of drug is effective in some patients
and not … If the drug was
working in the first place, why would the patient be put back on
the old drug rather … class of drug on the epilepsy
syndrome. … Therefore, when exploring this
topic, concentration, drug-drug interactions, and the fact that
phenytoin … the first drug prescribed for the patient.
-
effectivehealthcare.ahrq.gov/products/allergy-seasonal/research
July 16, 2013 - Food and Drug Administration (FDA).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
March 01, 2012 - Nevertheless, the drug is still
widely prescribed. … , and single drug versus single drug
comparisons for drugs within the same class and across
classes … versus placebo,
and comparisons of drug versus drug, for drugs within
the same class and across classes … The Food and Drug Administration’s Osteoporosis
Guidance Document: past, present, and future. … Rockville, MD: Food and Drug Administration, Division of
Metabolic and Endocrine Drug Products; 1994
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
June 29, 2019 - metabolism, polypharmacy (resulting in
drug-drug interactions), compromised respiration, hypogonadism … Adults: 2015 National Survey on Drug Use and Health. … High Prevalence of Drug-Drug
Interactions in Primary Health Care is Caused by Prescriptions from other … Reducing the risk of adverse drug
events in older adults. … Am J Drug Alcohol Abuse.
2015;41(6):508-518.
39.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
September 23, 2016 - Drug Class Review of Atypical Antipsychotic Drugs;
Update 3. … Portland, OR: Oregon Health & Science University Drug Effectiveness Review Project;
2010.
17. … Antipsychotic drug use and mortality in older adults
with dementia. … Drug Class Review: Second Generation Antipsychotic
Drugs. Final Report - Update 4. … Methods for the Drug Effectiveness Review Project.
BMC Med Res Methodol. 2012;12(1):140.
34.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
September 01, 2011 - That raises the question: Why focus on
off-label use since expanding FDA approval for an approved drug … We included studies
comparing atypicals to other
drug classes throughout the
report. … Similarly, our summary table of
benefits (Table 1) lists each
drug seperately for each
indication. … Pharmacoepidemiology and drug safety (2011) DOI: 10.1002/pds.2082 The study
results
indicated 75% … In addition, it shows a trend towards worsening
psychosis with this drug.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - The
drug/device has been approved in Europe. … Food and Drug Administration
(FDA); 2012 Nov 9. 63 p. … Drug list search results:
bydureon. [internet]. … FDA approves eye drug for diabetics.
[internet]. … Drug formulary.
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - Food and Drug Administration (FDA). … Food and Drug Administration (FDA). … Drug list search results:
bydureon. [internet]. … FDA approves eye drug for diabetics.
[internet]. … Drug formulary.
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - The a priori determined unit of analysis
was drug class. … In some instances, where only a single
drug was represented in a class, we
provide that drug name so … , not just by drug class vs. … When data for a single
drug was available, the drug level
comparison is presented (ex. duloxetine … In the “Discussion” chapter under
“applicability” we have added “Resulting
drug-drug interactions and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - The a priori determined unit of analysis
was drug class. … In some instances, where only a single
drug was represented in a class, we
provide that drug name so … , not just by drug class vs. … When data for a single
drug was available, the drug level
comparison is presented (ex. duloxetine … In the “Discussion” chapter under
“applicability” we have added “Resulting
drug-drug interactions and
-
effectivehealthcare.ahrq.gov/products/chronic-fatigue/research-protocol
May 01, 2014 - Food and Drug Administration (FDA) approved medications for the treatment of ME/CFS, but many have been … Food and Drug Administration’s (FDS’s) patient-focused drug development initiative, treatments fell into … PMID: 17559660
Center for Drug Evaluation and Research. … Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. … Food and Drug Administration; 2013.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-persons-who-present-with-acute-cough-illness-aci-what-is-the-comparative-effectiveness-of-various-interventions-for-reducing-inappropriate-antimicrobial-use
April 12, 2012 - unnecessary antibiotic prescribing which will in turn reduce costs, time to return to work, adverse drug … Drug resistance, development of serious complications, mortality from any cause, side effects due to … duration of hospital stay
Appropriateness for EHC Program
Does your question include a health care drug
-
effectivehealthcare.ahrq.gov/products/adhd-heart-disease-adults/research
November 01, 2011 - Food and Drug Administration (FDA) Adverse Event Reporting System data have raised concern that attention-deficit … Measurements
Baseline and follow-up drug use was assessed from automated records of dispensed prescriptions